In an exploratory study of 246 Korean T2D patients with DPP-4 inhibitor treatment for at least 24 weeks, the effects of the GLP1R rs3765467 G > A genetic variant on DPP-4 inhibitor responses were investigated [33]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.